• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿慢性肺疾病流行病学及发病机制的变化趋势

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

作者信息

Rojas M A, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G

机构信息

Department of Pediatrics, University of Miami School of Medicine, FL 33101, USA.

出版信息

J Pediatr. 1995 Apr;126(4):605-10. doi: 10.1016/s0022-3476(95)70362-4.

DOI:10.1016/s0022-3476(95)70362-4
PMID:7699543
Abstract

OBJECTIVE

To assess the role of specific risk factors that may predispose preterm infants with mild or no initial respiratory distress syndrome to the development of chronic lung disease (CLD).

STUDY DESIGN

Clinical data were collected prospectively from 119 ventilator-supported preterm infants with birth weights between 500 and 1000 gm, who survived more than 28 days and required fewer than 3 days of treatment with fraction of inspired oxygen > 25% during the first 5 days of life. Logistic regression analysis was used in a multivariate assessment of risk factors for CLD.

RESULTS

Chronic lung disease occurred in 44 of the patients (37%). The analysis showed that low birth weight, patent ductus arteriosus (PDA), and sepsis were significant risk factors for CLD. The corresponding odds ratios for CLD and their 95% confidence intervals (CI) were as follows: 2.9 per 100 gm birth weight decrement (CI, 1.7 to 4.8); 6.2 (CI, 2.1 to 18.4) for PDA; and 4.4 (CI, 1.3 to 14.5) for sepsis. When sepsis and PDA occurred simultaneously, the odds ratio for CLD increased to 48.3 (CI, 6.3 to > 100) in comparison with infants without these conditions. Episodes of PDA were categorized as either early (occurring during the first week of life) or late (after the first week), and the respective odds ratios for CLD were 2.8 (CI, 0.8 to 9.4) and 21.1 (CI, 5.6 to 80) in comparison with infants without PDA. For the duration of symptomatic PDA, the odds ratio for CLD was 3.5 per week that the PDA remained open (CI, 1.9 to 6.5).

CONCLUSION

CLD is a frequent sequela in very low birth weight infants with mild or no respiratory distress syndrome. In this population, the development of late episodes of PDA, usually in association with a nosocomial infection, seems to play a primary role in the pathogenesis of CLD.

摘要

目的

评估可能使轻度或无初始呼吸窘迫综合征的早产儿易患慢性肺病(CLD)的特定危险因素的作用。

研究设计

前瞻性收集了119例出生体重在500至1000克之间、存活超过28天且在出生后前5天内接受吸入氧分数>25%治疗少于3天的机械通气支持的早产儿的临床数据。采用逻辑回归分析对CLD的危险因素进行多因素评估。

结果

44例患者(37%)发生了慢性肺病。分析表明,低出生体重、动脉导管未闭(PDA)和败血症是CLD的显著危险因素。CLD的相应比值比及其95%置信区间(CI)如下:出生体重每降低100克为2.9(CI,1.7至4.8);PDA为6.2(CI,2.1至18.4);败血症为4.4(CI,1.3至14.5)。当败血症和PDA同时发生时,与无这些情况的婴儿相比,CLD的比值比增至48.3(CI,6.3至>100)。PDA发作分为早期(出生后第一周内发生)或晚期(第一周后),与无PDA的婴儿相比,CLD的相应比值比分别为2.8(CI,0.8至9.4)和21.(CI,5.6至80)。对于有症状的PDA持续时间,PDA保持开放每周CLD的比值比为3.5(CI,1.9至6.5)。

结论

CLD是轻度或无呼吸窘迫综合征的极低出生体重婴儿常见的后遗症。在这一人群中,通常与医院感染相关的晚期PDA发作似乎在CLD的发病机制中起主要作用。

相似文献

1
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.新生儿慢性肺疾病流行病学及发病机制的变化趋势
J Pediatr. 1995 Apr;126(4):605-10. doi: 10.1016/s0022-3476(95)70362-4.
2
Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.感染对体重1000克及以下早产儿动脉导管未闭和慢性肺病的影响。
J Pediatr. 1996 Apr;128(4):470-8. doi: 10.1016/s0022-3476(96)70356-6.
3
Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.表面活性剂时代慢性肺病的危险因素:一项基于北卡罗来纳州极低出生体重婴儿的人群研究。北卡罗来纳州新生儿科医生协会。
Pediatrics. 1999 Dec;104(6):1345-50. doi: 10.1542/peds.104.6.1345.
4
Changes in the pathogenesis and prevention of chronic lung disease of prematurity.早产儿慢性肺病发病机制及预防的变化
Am J Perinatol. 2001;18(1):1-9. doi: 10.1055/s-2001-12940.
5
Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.重复使用环氧化酶抑制剂未能关闭动脉导管未闭(PDA)是极低出生体重儿(ELBW)发生慢性肺部疾病的危险因素。
BMC Pediatr. 2012 Jan 27;12:10. doi: 10.1186/1471-2431-12-10.
6
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
7
Chronic lung disease in very low birthweight infants: a 5-year review.极低出生体重儿慢性肺部疾病:一项5年回顾
J Paediatr Child Health. 1997 Apr;33(2):102-6. doi: 10.1111/j.1440-1754.1997.tb01009.x.
8
Patent ductus arteriosus in premature infants: to treat or not to treat?早产儿动脉导管未闭:治疗还是不治疗?
J Perinatol. 2017 Jun;37(6):652-657. doi: 10.1038/jp.2017.4. Epub 2017 Feb 16.
9
Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.吸入性糖皮质激素与全身性糖皮质激素预防机械通气的极低出生体重早产儿慢性肺病的比较
Cochrane Database Syst Rev. 2003(1):CD002058. doi: 10.1002/14651858.CD002058.
10
Early introduction of lipids to parenterally-fed preterm infants.对经肠道外喂养的早产儿尽早引入脂质。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005256. doi: 10.1002/14651858.CD005256.

引用本文的文献

1
Strategies for the prevention of bronchopulmonary dysplasia.预防支气管肺发育不良的策略。
Front Pediatr. 2024 Jul 24;12:1439265. doi: 10.3389/fped.2024.1439265. eCollection 2024.
2
Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.吸入性支气管扩张剂预防和治疗早产儿慢性肺部疾病。
Cochrane Database Syst Rev. 2024 Apr 9;4(4):CD003214. doi: 10.1002/14651858.CD003214.pub4.
3
Lactobacillus plantarum L168 improves hyperoxia-induced pulmonary inflammation and hypoalveolarization in a rat model of bronchopulmonary dysplasia.
植物乳杆菌 L168 改善支气管肺发育不良大鼠模型中高氧诱导的肺部炎症和肺泡发育不全。
NPJ Biofilms Microbiomes. 2024 Mar 29;10(1):32. doi: 10.1038/s41522-024-00504-w.
4
A clinical informatics approach to bronchopulmonary dysplasia: current barriers and future possibilities.支气管肺发育不良的临床信息学方法:当前障碍与未来可能性
Front Pediatr. 2024 Feb 12;12:1221863. doi: 10.3389/fped.2024.1221863. eCollection 2024.
5
Heat shock protein 70 protects the lungs from hyperoxic injury in a neonatal rat model of bronchopulmonary dysplasia.热休克蛋白 70 可保护支气管肺发育不良新生大鼠模型的肺免受高氧损伤。
PLoS One. 2023 May 18;18(5):e0285944. doi: 10.1371/journal.pone.0285944. eCollection 2023.
6
Perinatal origins of bronchopulmonary dysplasia-deciphering normal and impaired lung development cell by cell.支气管肺发育不良的围产期起源——逐细胞解析正常和受损的肺发育
Mol Cell Pediatr. 2023 Apr 18;10(1):4. doi: 10.1186/s40348-023-00158-2.
7
Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors.极早早产儿支气管肺发育不良:一项识别风险因素的范围综述
Biomedicines. 2023 Feb 14;11(2):553. doi: 10.3390/biomedicines11020553.
8
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.动脉导管未闭与支气管肺发育不良相关肺动脉高压的发生。
Am J Respir Crit Care Med. 2023 Apr 1;207(7):921-928. doi: 10.1164/rccm.202203-0570OC.
9
Racial disparities in the development of comorbid conditions after preterm birth: A narrative review.早产儿并发疾病发展中的种族差异:叙事性综述。
Semin Perinatol. 2022 Dec;46(8):151657. doi: 10.1016/j.semperi.2022.151657. Epub 2022 Aug 28.
10
Machine learning for prediction of bronchopulmonary dysplasia-free survival among very preterm infants.机器学习预测极早产儿支气管肺发育不良无生存时间。
BMC Pediatr. 2022 Sep 13;22(1):542. doi: 10.1186/s12887-022-03602-w.